Research article · 5 Jan 2022
Conference abstractPublished 6 Oct 2015
Identifying new targets in leukemogenesis using computational approaches
Bhagwan Mahavir Medical Research Centre, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Acute Lymphoblastic Leukemia (ALL) is a hematopoietic cancer predominant in children and involves many aberrant pathways. There is a need to identify novel targets to improve our understanding of disease biology and for developing new therapeutics. Hence, the aim of our study was to uncover new genes as targets using in silico approaches. We first analyzed Oncomine microarray database to profile the top 10% overexpressed genes of significance. These were then prioritized using ENDEAVOUR, DIR and TOPPGene online tools to identify novel candidate disease genes. Thirty training genes, overexpressed in ALL were retrieved from PubMed literature search to train the tools. Further, the functional association networking of the prioritized and training genes was investigated using STRING protein interaction database. The network was then analysed using cytoHubba tool to identify highly connected hub genes. From our analysis of Oncomine database, 530 genes were shortlisted which on prioritization revealed fifty four genes to be significant candidate leukemogenic genes. Our hub analysis of the protein network led to identification of two novel genes, SMAD2 and CDK9, which were not implicated in leukemogenesis earlier. Filtering out from several hundred genes in the network we also found MEN1, HDAC1 and LCK genes to be important hubs, which re-emphasized their important role in leukemogenesis. This is the first report on these five additional signature genes in leukemogenesis. Our findings suggest that these genes could serve as new targets for developing novel therapeutics and also as biomarkers in leukemogenesis, which could be important for prognosis and diagnosis.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 13 Mar 2017
New Drug Candidates for Liposomal Delivery Identified by Computer Modeling of Liposomes' Remote Loading and Leakage
Conference abstract · 18 Mar 2019
Drug repurposing approach to identify novel inhibitors for targeting DNA gyrase in Mycobacterium tuberculosis: insights into mechanism and drug action
Article · 2011
An insilico approach to identify drug targetable protein in Visceral Leishmaniasis using GC MS extracted active components from Aloe vera
Article · 29 Dec 2024
Optimizing Ultrasound Parameters for Targeted Blood-Brain Barrier Disruption: A Computational Approach
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kaiser Jamil”
